Purchase Order 36C25626P0041
- Not listed
- The Department of Veterans Affairs' Veterans Integrated Service Network 6 awarded a $198,080.05 delivery order to Cepheid for molecular diagnostic testing system reagents, assays, and equipment lease services. This firm fixed-price contract, with an ultimate completion date of September 30, 2025, represents a non-set-aside procurement supporting the VA's clinical laboratory and diagnostic capabilities. Cepheid, a Sunnyvale-based manufacturer of advanced molecular diagnostic solutions, will...
- The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 6 awarded a delivery order to Cepheid Inc. for Cepheid Molecular Diagnostic Testing System Reagents and Assays valued at $537,017.20, effective October 1, 2025, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was awarded without set-aside designation and represents a task order issued under Cepheid's larger IDV vehicle with VISN 6, which holds a total ceiling value of $32.8...
- Cepheid has been awarded a delivery order valued at $341,103.30 for Cepheid Molecular Diagnostic Testing System Reagents and Assays under the Veterans Integrated Service Network (VISN) 6 Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This firm fixed-price delivery order was awarded on October 14, 2025, with an ultimate completion date of March 31, 2026. The contract carries no set-aside designation and is funded by the Department of Veterans Affairs through VISN 6. Cepheid, a...
- This delivery order, awarded on October 1, 2025, to Cepheid Inc. for $299,404 provides molecular diagnostic testing system reagents and assays to Veterans Integrated Service Network (VISN) 6 through March 31, 2026. The contract utilizes a firm fixed-price structure with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will supply products and services supporting infectious disease detection and clinical testing across VISN 6's...
- Cepheid has been awarded a delivery order valued at approximately $310K for molecular diagnostic testing system reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6), a component of the Department of Veterans Affairs' healthcare system. This firm fixed-price delivery order, with no set-aside designation, will be performed through March 31, 2026, and represents a continuation of Cepheid's ongoing supply of diagnostic solutions to the VA's regional health networks. The...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order to Cepheid Inc. for a molecular analyzer lease and cost-per-test arrangement with a ceiling value of $1.23M and an ultimate completion date of January 18, 2026. This firm fixed-price delivery order, which carries no set-aside designation, is issued under a larger Indefinite Delivery Vehicle (IDV) contract. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic...
- Cepheid Inc., a leading manufacturer of molecular diagnostic systems based in Sunnyvale, California, was awarded a delivery order valued at $970,216.62 on October 1, 2025, for Cepheid Molecular Diagnostic Testing System reagents and assays supporting Veterans Integrated Service Network 6 (VISN 6). This firm fixed-price delivery order, which extends through March 31, 2026, carries no set-aside designation and will be performed in Sunnyvale, California. The award funds the supply of molecular...
- The U.S. Department of Veterans Affairs (VA) awarded a $253,721.76 firm fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for CEPHEID MOLECULAR DIAGNOSTIC TESTING SYSTEM REAGENTS, ASSAYS, AND LEASE FOR VISN 6, with an ultimate completion date of January 8, 2025. The contract does not have a set-aside designation. Cepheid is providing the VA's Veterans Integrated Service Network 6 (VISN 6) with its molecular diagnostic...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a purchase order valued at $5.17 million by the Department of Veterans Affairs' Veterans Integrated Service Network 8 on October 1, 2022. This firm fixed-price contract, with no set-aside designation, is a modification to an existing agreement that adjusts clinical quantities based on updated workload estimates for microbiology testing services. The contract calls for an all-inclusive...
- The Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20) awarded a delivery order to Cepheid Inc. on September 9, 2025, for reagents and consumables for laboratory tests, with a ceiling value of $779,868.80 and an ultimate completion date of September 8, 2026. This firm fixed-price delivery order has no set-aside designation and represents a task order to add new Contract Line Item Numbers (CLINs) to an existing vehicle. The work will be performed in Sunnyvale,...
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a firm fixed-price purchase order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, with a ceiling value of $1.2M and a completion date of September 30, 2030. This contract covers Cepheid reagents and related molecular diagnostic testing solutions. The award carries no set-aside designation and reflects VISN 16's ongoing procurement of advanced diagnostic capabilities to support veterans' healthcare delivery across its network. Cepheid specializes in GeneXpert diagnostic systems and molecular test kits designed to detect infectious diseases including COVID-19, influenza, respiratory syncytial virus, MRSA, and other clinical conditions. This purchase order represents a component of Cepheid's broader federal contract portfolio with the VA system. The company maintains two significant Indefinite Delivery Vehicle contracts with VA networks, including a $32.8M single-award IDV with VISN 6 and a $2.5M contract with VISN 21, both extending through September 2030. These vehicles establish the framework for continuous procurement of molecular diagnostic testing systems and reagents across the VA healthcare network. Cepheid's federal presence also extends to the Indian Health Service and Defense Logistics Agency, positioning the company as a primary supplier of molecular diagnostic solutions within federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $241.7k | 10/1/25 |